Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Kennedy disease, Neoplasms by Site, Skin and Connective Tissue Diseases, X-linked disease, breast disorder, breast neoplasm, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, motor neuron disorder, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, skin disorder, spinal cord disorder, spinal muscular atrophy, triple-negative breast carcinoma	Recruiting	Phase 2	2026-04-01		NCT06365788

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eli Lilly and Company	370
Kom Op Tegen Kanker	20
Teva Pharma	1
Universitaire Ziekenhuizen KU Leuven	262

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Antwerp University Hospital	Antwerp	Belgium	12
Ghent University Hospital	Ghent	Belgium	21
Jessa Ziekenhuis	Hasselt	Belgium	18
University Hospital Brussels	Brussels	Belgium	1
University Hospitals Leuven	Leuven	Belgium	14
ZAS Augustinus	Antwerp	Belgium	6